Rhodamine 6G efflux for the detection of CDR1-overexpressing azole-resistant Candida albicans strains

Journal of Antimicrobial Chemotherapy

Volumn 44, Issue 1, 1999, Pages 27-31

  Maesaki, Shigefumi ^a   Marichal, Patrick ^b   Vanden Bossche, Hugo ^b   Sanglard, Dominique ^c   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BENOMYL; FLUCONAZOLE; GLUCOSE; MESSENGER RNA; PHOSPHATE; PYRROLE; RHODAMINE 6G; SODIUM CHLORIDE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CELL GROWTH; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG ACCUMULATION; DRUG RESISTANCE; DRUG TRANSPORT; FUNGAL GENETICS; GENE OVEREXPRESSION; NONHUMAN; STATISTICAL ANALYSIS; STRAIN DIFFERENCE; YEAST CELL;

ANTIFUNGAL AGENTS; AZOLES; BENOMYL; CANDIDA ALBICANS; COLORING AGENTS; DRUG RESISTANCE, MICROBIAL; FUNGAL PROTEINS; GENES, MDR; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; RHODAMINES;

EID: 0032865613     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/44.1.27     Document Type: Article

References (14)

1. Willocks, L., Leen, C. L. S., Brettle, R. P., Urquhart, D., Russell, T. B. & Milne, L. J. R. (1991). Fluconazole resistance in AIDS patients. Journal of Antimicrobial Chemotherapy 28, 937-9.
2. Johnson, E. M., Warnock, D. W., Luker, J., Porter, S. R. & Scully, C. (1995). Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidiasis. Journal of Antimicrobial Chemotherapy 35, 103-14.
3. Law, D., Moore, C.B., Wardle, H.M., Ganquli, L.A., Keaney, M. G., Denning, D.W. et al. (1994). High prevalence of antifungal resistance in Candida spp. from patients with AIDS. Journal of Antimicrobial Chemotherapy 34, 659-68.
4. National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. NCCLS, Villanova, PA.
5. Rex, J. H., Pfaller, M. A., Galgiani, J. N, Bartlett, M. S., Espinellngroff, A., Ghannoum, M. A. et al. (1996). Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clinical Infectious Diseases 24, 235-47.
6. Revankar, S. G., Kirkpatrick, W. R., McAtee, R. K., Fothergill, A. W., Redding, S. W., Rinaldi, M. G. et al. (1998). Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method. Antimicrobial Agents and Chemotherapy 36, 153-6.
7. Vanden Bossche, H., Marichal, P. & Odds, F. C. (1994). Molecular mechanisms of drug resistance in fungi. Trends in Microbiology 2, 393-400.
8. Vanden Bossche, H., Warnock, D. W., Dupont, B., Kerridge, D., Gupta, S. S., Improvisi, L. et al. (1994). Mechanisms and clinical impact of antifungal drug resistance. Journal of Medical and Veterinary Mycology 32, suppl 1, 189-202.
9. White, T. C. (1998). Antifungal drug resistance in Candida albicans. ASM News 63, 427-33.
10. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M. & Bille, J. (1995). Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrobial Agents and Chemotherapy 39, 2378-86.
11. Goldway, M., Teff, D., Schmidt, R., Oppenheim, A. B. & Koltin, Y. (1995). Multiple resistance in Candida albicans: Disruption of the BEW gene. Antimicrobial Agents and Chemotherapy 39, 422-6.
12. Lee, J. S., Paull, K., Alvarez, M., Hose, C., Monks, A., Grever, M. et al. (1994). Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Molecular Pharmacology 46, 627-38.
13. Clark, F. S., Parkinson, T., Hitchcock, C. A. & Gow, N. A. R. (1996). Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: Possible role for drug efflux in drug resistance. Antimicrobial Agents and Chemotherapy 40, 419-25.
14. Maesaki, S., Marichal, P., Hossain, M. A., Sanglard, D., Vanden Bossche, H. & Kohno, S. (1998). Synergic effects of tacrolimus and azole antifungal agents against azole-resistant Candida albicans strains. Journal of Antimicrobial Chemotherapy 42, 747-53.